feed,title,long_url,short_url
Benzinga,Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients,https://benzinga.com/general/biotech/21/12/24601487/sanofi-reveals-late-stage-data-for-fitusiran-in-hemophilia-patients,https://j.mp/3m2wpqo
Benzinga,Cabaletta Bio's Cell Therapy Fails To Show Activity At Low Doses In Skin Blistering Disorder,https://benzinga.com/general/biotech/21/12/24595145/cabaletta-bios-cell-therapy-fails-to-show-activity-at-low-doses-in-skin-blistering-disorder,https://j.mp/31Pi6yV
Benzinga,Generation Bio Hits 52-Week Low After Preclinical Data From Hemophilia A Program,https://benzinga.com/general/biotech/21/12/24596323/generation-bio-hits-52-week-low-after-preclinical-data-from-hemophilia-a-program,https://j.mp/3pTpMIo
